Cancer News

Jul 2, 2009 - One of the most important challenges in the cancer community today is whether people can, in fact, prevent their own cancers.

A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended.

The Skin Cancer Foundation's Road To Healthy Skin Tour is offering free skin cancer screenings at Rite Aid in Jackson.

The former president of the Philippines, Corazon Aquino, has told he doctors she no longer wishes to be treated in her battle against colon cancer.

Brynessa Gradley's life changed just over a year ago when she scratched an itchy spot on her leg as she came out of the shower.

A new targeted therapy shows promise in treating acute myeloid leukemia, a highly treatment-resistant blood cancer, according to a new study.

A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended.

Two dietary supplements - vitamin D and fish oil - will soon undergo a five-year test of their effectiveness in lowering the rates of several major diseases.

Myriad Pharmaceuticals, Inc. today announced that it has completed its previously announced spin-off from Myriad Genetics, Inc.

A thriving construction business, a precious 11 year old daughter and a happy long-term relationship.

Survivors of childhood cancer run particular risks when pregnant and should be closely monitored, the 25th annual conference of the European Society of Human Reproduction and Embryology heard today .

An 84-year-old University of Chicago researcher has won a half-million-dollar genetics prize for her pioneering work in showing that cancer is a genetic disease.

Anglo-Swedish drugmaker AstraZeneca said Wednesday that one of its previously-sidelined drugs has obtained European marketing authorization, a move that could inject more life into the firm's drug portfolio.

AB Science, a young Paris-based biotech company, announces the pan-European commercial launch of its Masivet veterinary anticancer drug in June 2009.

Pfizer Inc said a late stage trial testing its cancer drug Sutent in advanced colon cancer was discontinued after it was deemed to be no more effective than standard chemotherapy.

"A new way of treating cancer has shown 'great promise' in its first clinical trial," the Financial Times reported.

Rexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has signed an exclusive collaboration and option for license agreement with a top 20 global pharmaceutical company for the development of RX-3117. RX-3117 is a small molecule, new ...

Finnish Academy Professors Lauri Aaltonen and Jussi Taipale have identified and described a mechanism whereby a single-base change in the human genome increases the risk of colorectal cancer.

In Health Watch: While there have been breakthroughs in breast cancer treatment doctors still struggle with rare form called inflammatory breast cancer... the most lethal form of the disease.

Australian researchers are set to begin human trials of a tiny nano-cell that acts as a "Trojan horse" against cancer cells, a breakthrough they say may curb the need for debilitating chemotherapy.